SLC5A2 and liver dysplastic nodule: Notably, recently developed reno-protective drugs, such as sodium-glucose cotransporter-2 (SGLT-2) inhibitors, also have shown promising anti-inflammatory and anti-oxidative stress effects in the treatment of DN (14).